Alpa Laboratories Limited

ALPA

INE385I01010

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 08:02:02 18/05/2024 BST			5-day change	1st Jan Change
89.75 ^INR	+0.56%		+0.62%	-13.12%

02-13	Alpa Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
02-13	Alpa Laboratories Limited Announces Reconstitution of Committees	CI

Alpa Laboratories Limited Announces Resignation of Aditya Singh as Company Secretary and Compliance Officer

August 03, 2021 at 11:11 am

Alpa Laboratories Limited announced that Mr. Aditya Singh has resigned from the post of Company Secretary of Alpa Laboratories Limited, effective closing of business hours of 2 August,2021. Consequent to his resignation as company secretary of the Company, he also ceases to be the compliance officer of the company as per Regulation 6 of the SEB! (LODR) Regulations.

Latest news about Alpa Laboratories Limited

Alpa Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-13	CI
Alpa Laboratories Limited Announces Reconstitution of Committees	02-13	CI
Alpa Laboratories Limited Announces Directors Appointments	28/08/23	CI
Alpa Laboratories Limited Appoints Shitul Shah as an Additional Director	16/08/23	CI
Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/08/23	CI
Alpa Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2023	29/05/23	CI
Alpa Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	29/05/23	CI
Alpa Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14/02/23	CI
Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	13/08/22	CI
Alpa Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	28/05/22	CI
Alpa Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	14/02/22	CI
Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	14/08/21	CI
Alpa Laboratories Limited Appoints Swati Bagh as Company Secretary Cum Compliance Officer	14/08/21	CI
Alpa Laboratories Limited Announces Resignation of Aditya Singh as Company Secretary and Compliance Officer	03/08/21	CI
Alpa Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	30/06/21	CI
Alpa Laboratories Limited Appoints Aditya Singh as Company Secretary Cum Compliance Officer	10/03/21	CI
Alpa Laboratories Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	12/02/21	CI
Alpa Laboratories Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	12/11/20	CI
Alpa Laboratories Limited Announces Executive Changes	14/10/20	CI
Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2020	25/08/20	CI
Alpa Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020	29/06/20	CI
Alpa Laboratories Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019	14/02/20	CI
Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2019	14/08/19	CI
Alpa Laboratories Limited Announces Unaudited Standalone Earnings Results for the Fourth Quarter and Audited Standalone and Consolidated Earnings Results for the Full Year Ended March 31, 2019	27/05/19	CI
Alpa Laboratories Ltd. Announces Unaudited Standalone Earnings Results for the Quarter and Nine Months Ended December 31, 2018	09/02/19	CI

Chart Alpa Laboratories Limited

Duration

Period

More charts

Company Profile

Alpa Laboratories Limited is an India-based company, which is engaged in manufacturing and selling pharmaceutical finished dosage forms. The Companyâs product range includes a wide variety of ethical, generic, and over the counter (OTC) drugs in various finished dosage forms for both human and veterinary use. Its human use products include capsules, such as Ampicillin Capsule IP/BP, Amoxycillin Trihydrate Capsule IP/BP, Cloxacillin Capsules IP/BP and Piroxicam Capsules IP BP; creams, gels and ointments, which include Lidocaine Hydrochloride Jelly IP/USP, Nitrofurazone Cream USP, Miconazole Cream IP/BP and Clobetasole Ointment/Cream BP; ear and eye drops, such as Benzylpenicillin Inj. IP/BP and Benzathine Penicillin Inj. IP/BP, and tablets, such as Ciprofloxacin Tablet IP / BP, Paracetamol Tablet IP/BP and Tinidazole Tablets IP/BP. Its veterinary products include boluses, such as Alpamin Bolus, Melovin-P Bolus and Alpazole Bolus, and injections, such as Atropine Inj. B.Vet.C and others.

Sector

Pharmaceuticals

Calendar

27/05/2024 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
ALPA LABORATORIES LIMITED	-13.12%	22.54M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.63%	44.11B
OTSUKA HOLDINGS CO., LTD.	+23.03%	22.71B
SANDOZ GROUP AG	+18.22%	15.15B
CIPLA LIMITED	+12.66%	13.56B
ZYDUS LIFESCIENCES LIMITED	+60.18%	12.7B
ONO PHARMACEUTICAL CO., LTD.	-10.02%	6.84B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+12.92%	5.63B